Suspension of trading

Valuation OPTINOSEPAR

Stocks

Delayed Nasdaq Other stock markets 00:00:00 21/05/2025 +04			5-day change	1st Jan Change
9.600 ^USD	-1.13%		-.--%	-

23/05/25	OptiNose, Inc.(NasdaqGS:OPTN) dropped from S&P Global BMI Index	CI
23/05/25	OptiNose, Inc.(NasdaqGS:OPTN) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Market Cap ¹	422.7	215.6	133.2	203.2	144.9	67.17
Change	-	-48.99%	-38.24%	52.6%	-28.7%	-53.64%
Enterprise Value (EV) ¹	351.6	202.9	153.4	240.1	202.9	111.6
Change	-	-42.28%	-24.42%	56.58%	-15.48%	-44.99%
P/E	-3.51x	-2x	-1.12x	-2.12x	-4.07x	-3.15x
PBR	6.87x	32.3x	-6.12x	-3.64x	-1.67x	-1.66x
PEG	-	0.1x	0x	0.1x	0.1x	0.1x
Capitalization / Revenue	12.2x	4.39x	1.78x	2.66x	2.04x	0.86x
EV / Revenue	10.2x	4.13x	2.05x	3.15x	2.86x	1.43x
EV / EBITDA	-3.72x	-2.37x	-2.33x	-4.34x	-9.08x	-6.96x
EV / EBIT	-3.68x	-2.33x	-2.31x	-4.3x	-8.92x	-6.84x
EV / FCF	-6.46x	-4x	-3.37x	-6.14x	-26.4x	-3.28x
FCF Yield	-15.5%	-25%	-29.7%	-16.3%	-3.79%	-30.5%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-39.42	-31.01	-21.71	-13.07	-4.749	-2.121
Distribution rate	-	-	-	-	-	-
Net sales ¹	34.63	49.12	74.65	76.28	70.99	78.23
EBITDA ¹	-94.49	-85.76	-65.8	-55.36	-22.35	-16.04
EBIT ¹	-95.6	-87.22	-66.45	-55.9	-22.75	-16.32
Net income ¹	-110.1	-99.78	-82.3	-74.83	-35.48	-21.54
Net Debt ¹	-71.08	-12.68	20.2	36.93	58.06	44.48
Reference price ²	138.300	62.100	24.300	27.750	19.350	6.680
Nbr of stocks (in thousands)	3,056	3,472	5,480	7,323	7,487	10,055
Announcement Date	05/03/20	03/03/21	08/03/22	07/03/23	07/03/24	26/03/25

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
OPTINOSEPAR	-	-	-	-	97.22M
ELI LILLY AND COMPANY	34.02x	11.84x	24.88x	0.61%	995B
JOHNSON & JOHNSON	28.36x	6.26x	17.51x	2.11%	614B
ABBVIE INC.	31.72x	7.19x	14.9x	2.84%	431B
ROCHE HOLDING AG	19.93x	4.73x	11.72x	2.79%	353B
NOVARTIS AG	21.85x	5.66x	14.11x	2.84%	293B
ASTRAZENECA PLC	20.2x	4.19x	11.86x	2.11%	245B
AMGEN INC.	25.61x	6.68x	11.78x	2.59%	210B
NOVO NORDISK A/S	13.52x	5.15x	10.43x	3.7%	210B
GILEAD SCIENCES, INC.	-48.74x	5.83x	32.22x	2.44%	168B
Average	16.28x	6.39x	16.60x	2.45%	351.83B
Weighted average by Cap.	23.69x	7.54x	17.96x	2.04%